Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 4-ethoxy-2-methyl-5-morpholino-3(2h)-pyridazinone
2. M 73101
3. M-73101
4. M73101
1. 38957-41-4
2. Nandron
3. Pentoil
4. 4-ethoxy-2-methyl-5-morpholino-3(2h)-pyridazinone
5. M73101
6. 3(2h)-pyridazinone, 4-ethoxy-2-methyl-5-morpholino-
7. 4-ethoxy-2-methyl-5-(4-morpholinyl)-3(2h)-pyridazinone
8. V93u9dh62c
9. Emorfazona
10. Emorfazonum
11. Pentoyl
12. Emorfazone [inn:jan]
13. Emorfazone [inn-french]
14. Emorfazonum [inn-latin]
15. Emorfazona [inn-spanish]
16. Einecs 254-220-9
17. M 73101
18. Brn 0995465
19. Unii-v93u9dh62c
20. 4-ethoxy-2-methyl-5-morpholin-4-ylpyridazin-3-one
21. Pentoil (tn)
22. Emorfazone [mi]
23. Emorfazone [inn]
24. Emorfazone [jan]
25. Dsstox_cid_2981
26. Emorfazone (jp17/inn)
27. Dsstox_rid_97544
28. Emorfazone [who-dd]
29. Dsstox_gsid_22981
30. M-73101
31. Schembl26203
32. Zinc1349
33. Chembl2103954
34. Dtxsid0022981
35. Chebi:31535
36. 3(2h)-pyridazinone, 4-ethoxy-2-methyl-5-(4-morpholinyl)-
37. Tox21_113708
38. Ncgc00249932-01
39. Ph011085
40. Cas-38957-41-4
41. D01353
42. Sr-01000944985
43. Sr-01000944985-1
44. Q27291687
45. 4-(ethyloxy)-2-methyl-5-morpholin-4-ylpyridazin-3(2h)-one
| Molecular Weight | 239.27 g/mol |
|---|---|
| Molecular Formula | C11H17N3O3 |
| XLogP3 | 0 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 3 |
| Exact Mass | 239.12699141 g/mol |
| Monoisotopic Mass | 239.12699141 g/mol |
| Topological Polar Surface Area | 54.4 Ų |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 359 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
15
PharmaCompass offers a list of Emorfazone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Emorfazone manufacturer or Emorfazone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Emorfazone manufacturer or Emorfazone supplier.
PharmaCompass also assists you with knowing the Emorfazone API Price utilized in the formulation of products. Emorfazone API Price is not always fixed or binding as the Emorfazone Price is obtained through a variety of data sources. The Emorfazone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Emorfazone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Emorfazone, including repackagers and relabelers. The FDA regulates Emorfazone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Emorfazone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Emorfazone supplier is an individual or a company that provides Emorfazone active pharmaceutical ingredient (API) or Emorfazone finished formulations upon request. The Emorfazone suppliers may include Emorfazone API manufacturers, exporters, distributors and traders.
Emorfazone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Emorfazone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Emorfazone GMP manufacturer or Emorfazone GMP API supplier for your needs.
A Emorfazone CoA (Certificate of Analysis) is a formal document that attests to Emorfazone's compliance with Emorfazone specifications and serves as a tool for batch-level quality control.
Emorfazone CoA mostly includes findings from lab analyses of a specific batch. For each Emorfazone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Emorfazone may be tested according to a variety of international standards, such as European Pharmacopoeia (Emorfazone EP), Emorfazone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Emorfazone USP).
